Centra Lynchburg Hematology-Oncology Clinic Inc

Summary

Centra Lynchburg Hematology-Oncology Clinic Inc is a medical facility located in Lynchburg, Virginia. This center is recognized for care of Lung Cancer, Breast Cancer, Breast cancer, Non-Small Cell Lung Cancer, Prostate Cancer and other specialties. Centra Lynchburg Hematology-Oncology Clinic Inc is involved with conducting 103 clinical trials across 132 conditions. There are 11 research doctors associated with this hospital, such as Andrew Poklepovic, MD, Sarah W. Gordon, DO, Khalid Matin, and Erin R. Alesi.

Top PIs

Clinical Trials running at Centra Lynchburg Hematology-Oncology Clinic Inc

Lung Cancer

Multiple Myeloma

Breast Cancer

Ovarian Cancer

Cancer

Non-Small Cell Lung Cancer

Melanoma

Throat Cancer

Laryngeal Cancer

Fallopian Tube Cancer

Immunotherapy + Chemotherapy

for Non-Small Cell Lung Cancer

This phase III ALCHEMIST treatment trial tests the addition of pembrolizumab to usual chemotherapy for the treatment of stage IIA, IIB, IIIA or IIIB non-small cell lung cancer that has been removed by surgery. Immunotherapy with monoclonal antibodies, such as pembrolizumab, may help the body's immune system attack the cancer, and may interfere with the ability of tumor cells to grow and spread. Chemotherapy drugs, such as cisplatin, pemetrexed, carboplatin, gemcitabine hydrochloride, and paclitaxel, work in different ways to stop the growth of tumor cells, either by killing the cells, by stopping them from dividing, or by stopping them from spreading. Giving pembrolizumab with usual chemotherapy may help increase survival times in patients with stage IIA, IIB, IIIA or IIIB non-small cell lung cancer.

Recruiting

2 awards

Phase 3

27 criteria

Biobank Collection

for Cancer

This trial collects multiple tissue and blood samples, along with medical information, from cancer patients. The "Cancer Moonshot Biobank" is a longitudinal study. This means it collects and stores samples and information over time, throughout the course of a patient's cancer treatment. By looking at samples and information collected from the same people over time, researchers hope to better understand how cancer changes over time and over the course of medical treatments.

Recruiting

1 award

N/A

10 criteria